Male breast cancer in Cowden syndrome patients with germline PTEN mutations

Journal of Medical Genetics

Volumn 38, Issue 3, 2001, Pages 159-164

  Fackenthal, J D ^a   Marsh, D J ^b,c   Richardson, A L ^b,c   Cummings, S A ^a   Eng, C ^d,e   Robinson, B G ^b,c   Olopade, O I ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cowden syndrome; Male breast cancer; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CASE REPORT; CLINICAL FEATURE; COWDEN SYNDROME; FAMILY STUDY; GENE MUTATION; GENETIC PREDISPOSITION; GERM LINE; HUMAN; MACROCEPHALY; MALE; ONSET AGE; PAPILLOMATOSIS; PHENOTYPE; PRIORITY JOURNAL; THYROID ADENOMA; TRICHILEMMOMA; TUMOR SUPPRESSOR GENE;

EID: 0035088435     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.38.3.159     Document Type: Article

References (60)

1. Cowden's disease
2. Cowden's disease (multiple hamartoma syndrome)
3. Cowden's disease (multiple hamartoma syndrome)
4. Cowden's disease: A case report and review of the literarure
5. Cowden syndrome (multiple hamartoma syndrome)
6. Clinical and pathological features of breast disease in Cowden's syndrome: An underrecognized syndrome with an increased risk of breast cancer
7. Cowden syndrome
8. Cowden disease. Report of a family and review
9. Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature
10. The Cowden syndrome: A clinical and genetic study in 21 patients
11. Cowden's disease
12. Cowden syndrome
13. Cowden syndrome
14. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
15. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation
16. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
17. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease
18. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
19. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome
20. The role of MMAC1 mutations in early-onset breast cancer: Causative in association with Cowden syndrome and excluded in BRCA1-negative cases
21. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells
22. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
23. The lipid phosphatase activity of PTEN is critical for its rumor suppressor function
24. Regulation of cell death protease caspase-9 by phosphorylation
25. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
26. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
27. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
28. Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome
29. Clinicopathologic findings in the Bannayan-Riley-Ruvalcaba syndrome
30. Bannayan-Riley-Ruvalcaba syndrome
31. Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype
32. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
33. Macrocephaly with multiple lipomas and hemangiomas
34. Mutation analysis of the putative tumor suppression gene PTEN/MMAC1 in sporadic breast cancer
35. Genetics of Cowden syndrome: Through the looking glass of oncology
36. Identification of a candidate turnout suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
37. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
38. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10
39. Germline PTEN mutations in Cowden syndrome-like families
40. Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome
41. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma
42. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
43. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
44. Intracystic papillary carcinoma in the male breast. A case report
45. Carcinoma of the male breast in Zambia
46. Breast cancer in men: Risk factors with hormonal implications
47. Cancer of the breast in a male cirrhotic: Is there an association between the two?
48. Carcinoma of the male breast and Klinefelter's syndrome: Is there an association?
49. Malignant tumors of the breast
50. Male breast cancer
51. Immunocytochemical characterization of male breast cancer
52. Lack of c-erbB-2 oncoprotein expression in male breast carcinoma
53. Male breast carcinoma: An evaluation of prognostic factors contributing to a poorer outcome
54. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
55. Study of a single BRCA2 mutation with high carrier frequency in a small population
56. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13
57. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome